HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment

BACKGROUND: Pathologic complete response (pCR) to neoadjuvant treatment (NAT) is associated with improved survival of patients with HER2+ breast cancer. We investigated the ability of interim positron emission tomography (PET) regarding early prediction of pathology outcomes. METHODS: During 61 mont...

Descripción completa

Detalles Bibliográficos
Autores principales: Groheux, D, Giacchetti, S, Hatt, M, Marty, M, Vercellino, L, de Roquancourt, A, Cuvier, C, Coussy, F, Espié, M, Hindié, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778311/
https://www.ncbi.nlm.nih.gov/pubmed/23942075
http://dx.doi.org/10.1038/bjc.2013.469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778311/
https://www.ncbi.nlm.nih.gov/pubmed/23942075
http://dx.doi.org/10.1038/bjc.2013.469

Ejemplares similares